Industry News
Evidence-Based Treatment Can Be Improved By Greater Representation Of Elderly Patients In Phase III Trials
Feb 26, 2013
The median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased over the recent years and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials... Read More
Stivarga Approved By FDA For Advanced Gastrointestinal Stromal Tumors (GIST)
Feb 26, 2013
Stivarga (regorafenib), a cancer medication, has had its usage expanded to include patients suffering from advanced gastrointestinal stromal tumors (GIST) by the U.S. Food and Drug Administration. The drug is marketed by Bayer HealthCare Pharmaceuticals. GIST occurs when cancerous cells build up inside the gastrointestinal tract... Read More
Study Documents Head And Neck Cancer Molecular Tumor Subtypes
Feb 26, 2013
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common form of cancer in the United States, but other than an association with the human papillomavirus, no validated molecular profile of the disease has been established... Read More
Protein Uses Multiple Means To Help Cells Cope When Oxygen Runs Low
Feb 26, 2013
A protein known for turning on genes to help cells survive low-oxygen conditions also slows down the copying of new DNA strands, thus shutting down the growth of new cells, Johns Hopkins researchers report... Read More
Neuroscientist Sheds Light On Cause Of 'Chemo Brain'
Feb 26, 2013
It's not unusual for cancer patients being treated with chemotherapy to complain about not being able to think clearly, connect thoughts or concentrate on daily tasks. The complaint - often referred to as chemo-brain - is common. The scientific cause, however, has been difficult to pinpoint... Read More
Tanning Salons Allowing Children To Use Facilities
Feb 26, 2013
Despite the ever-increasing evidence of the health risks associated with using indoor tanning beds, a recent survey conducted on tanning salon operators in the state of Missouri revealed that 65 percent continue to allow kids as young as 10 to use their facilities. The finding was published in the journal Pediatrics... Read More
Evidence-Based Treatment Can Be Improved By Greater Representation Of Elderly Patients In Phase III Trials
Feb 26, 2013
The median age of patients diagnosed with advanced non-small-cell lung cancer (NSCLC) has steadily increased over the recent years and is presently 70 years. Despite this, the elderly are significantly underrepresented in clinical trials... Read More
Stivarga Approved By FDA For Advanced Gastrointestinal Stromal Tumors (GIST)
Feb 26, 2013
Stivarga (regorafenib), a cancer medication, has had its usage expanded to include patients suffering from advanced gastrointestinal stromal tumors (GIST) by the U.S. Food and Drug Administration. The drug is marketed by Bayer HealthCare Pharmaceuticals. GIST occurs when cancerous cells build up inside the gastrointestinal tract... Read More
New Clues To Epstein-Barr Virus
Feb 25, 2013
Epstein-Barr virus (EBV) affects more than 90 percent of the population worldwide and was the first human virus found to be associated with cancer. Now, researchers from Beth Israel Deaconess Medical Center (BIDMC) have broadened the understanding of this widespread infection with their discovery of a second B-cell attachment receptor for EBV... Read More
In Future It May Be Possible To Sniff Out The Side Effects Of Radiotherapy
Feb 25, 2013
Researchers at the University of Warwick and The Royal Marsden NHS Foundation Trust have completed a study that may lead to clinicians being able to more accurately predict which patients will suffer from the side effects of radiotherapy... Read More
Previous Page Next Page